This article was originally published in The Rose Sheet
Jean-Paul Agon is appointed CEO of French beauty giant during annual general meeting April 25 in Paris. Company announced plan for Agon to succeed Lindsay Owen-Jones, who retains his role as chairman, last year (1"The Rose Sheet" Feb. 21, 2005, p. 5). Agon will oversee integration of recently acquired British beauty retailer The Body Shop, which is "well underway," Owen-Jones states during the meeting. Outlining future growth opportunities for the company, Owen-Jones cites consumers over 60 and men as audiences to explore. L'Oréal is in a "strong position" to tap older customers with anti-aging products like Lancôme Platineum and has a number of brands targeted to men, including L'Oréal Paris Men Expert and Biotherm Homme, exec notes, adding sales of its men's products were up 17.8% in 2005...
You may also be interested in...
L'Oréal USA President Jean-Paul Agon will succeed Chairman and CEO Lindsay Owen-Jones at the helm of the French beauty company in 2006 under a new management structure in which Owen-Jones will retain his chairmanship
A draft Biosimilar Insulin Access Act, intended to waive US interchangeability requirements for FDA-approved biosimilar insulins, has been introduced by representative Glenn Grothman.
The former CEO of Cipla’s India business is set to steer JB Chemicals and Pharmaceuticals, as the Indian firm embarks on a new phase of growth, backed by a revamped board, following its takeover by US private equity firm KKR.